Neridronate
-
Neridronate
structure -
-
CAS No:
79778-41-9
-
Formula:
C6H17NO7P2
-
Chemical Name:
Neridronate
-
Synonyms:
Phosphonic acid,P,P′-(6-amino-1-hydroxyhexylidene)bis-;Phosphonic acid,(6-amino-1-hydroxyhexylidene)bis-;P,P′-(6-Amino-1-hydroxyhexylidene)bis[phosphonic acid];6-Amino-1-hydroxyhexane-1,1-diphosphonic acid;6-Amino-1-hydroxyhexylidenediphosphonic acid;Neridronic acid;6-Amino-1-hydroxyhexylidene-1,1-bis(phosphonic acid);Nerixia;Neridronate;(6-Amino-1-hydroxyhexane-1,1-diyl)diphosphonic acid;437763-00-3
- Categories:
-
CAS No:
Description
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases[1][2].
Neridronic acid is a 1,1-bis(phosphonic acid).|Neridronic Acid is a third-generation, aminohexane bisphosphonate with anti-resorptive and anti-hypercalcemic activities. Although the exact mechanism of action has yet to be fully elucidated, neridronic acid binds to and adsorbs onto hydroxyapatite crystals in bone matrix, thereby preventing osteoclast resorption. This agent also binds to and inhibits farnesyl pyrophosphate synthase, an enzyme that plays an important role in the mevalonate pathway. This inhibits the formation of isoprenoids that are substrates for protein prenylation. This prevents farnesylation and geranylgeranylation of proteins essential for osteoclast function, thereby leading to the induction of apoptosis of osteoclasts. By preventing osteoclast-mediated bone resorption, neridronic acid decreases bone turnover rate, stabilizes the bone matrix and reduces hypercalcemia.
Characteristics
161
-3.36
white solid
1.7±0.1 g/cm3
247-249 °C
600.1±65.0 °C at 760 mmHg
316.7±34.3 °C
1.569
H2O: 8 mg/mL, soluble
2-8°C
Safety Information
NONH for all modes of transport
3
22
Xn
P264, P270, P301+P312, P330, P501
H302
|Warning|H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 40 companies from 3 notifications to the ECHA C&L Inventory.
Computed Properties
Molecular Weight:277.15
XLogP3:-5.8
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:7
Exact Mass:277.04802588
Monoisotopic Mass:277.04802588
Topological Polar Surface Area:161
Heavy Atom Count:16
Complexity:286
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
APO-10
2190-95-6
-
Indium phosphide
22398-80-7
-
Dimethylvinphos
2274-67-1
-
(4-Methoxybenzyl)triphenylphosphonium chloride Formula
3462-97-3
-
(3-chloro-2-oxopropyl) dihydrogen phosphate Formula
23743-97-7
-
Piperophos Formula
24151-93-7
-
(2-bromo-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonic acid,hydrate Structure
209736-59-4
-
Dibutyl phenyl phosphate Structure
2528-36-1
-
What is P-(1Z)-1-Propen-1-ylphosphonic acid
25383-06-6
-
What is CGS35066
261619-50-5